Menu
The Biotav team has more than 30 years of research and development experience, focused on combating various infectious diseases and the production of innovative new drugs. The company applies its unparalleled knowledge to solving complex problems in the production of unique biopharmaceuticals capable of fighting the most dangerous diseases.
Adopting a “One Health” approach that recognizes the interdependence of human, animal, and environmental health, Biotav achieves breakthrough results by adapting its extensive experience in veterinary medicine to human medicine. The most advanced products in the company’s portfolio to date are an oncolytic viral brain cancer drug and an oral COVID-19 vaccine.
Biotav’s multi-disciplinary team has expertise both in the relevant areas of biology, pathology, and biopharmaceutical manufacturing, and in market and regulatory issues. The company has worked in strict compliance with the requirements of c-GMP and the European Pharmacopoeia from the outset.
With provisional patents and pending applications, a first-class GMP manufacturing facility, and a strong network of relationships with leading medical institutions and government agencies, Biotav has all the right ingredients/ elements to implement its unique products into medical practice.
Founder and Chairman
Expert in veterinary biologicals QC
Established GMP facility since 1995
Co-Founder and CEO
Strategic global executive leader
Extensive experience leading key growth initiatives in the tech industry
Chief Medical Consultant
CFO
Chief financial officer
CTO
Head of Fermentation and Lyophilization Department Biovac Ltd. Veterinary vaccines, Israel (1997-2012)
Marketing Manager
Extensive experience in sales, marketing communications, negotiations and strategic planning.
DVM, Pre-Clinical Triales
Meigal research laboratory (2016-2018)
QA/QC Manager
Monitoring, inspecting, and improving organization quality standards.
Verifying products compliance with MOH regulations.
BSc in animal science and D.V.M – Hebrew University of Jerusalem.
R&D and laboratory manager
Leading new products development and solutions
Planning and implementing new protocols and programs
BSc in animal science , Tel-Hai Academic College
PMO Operations Manager
“Since 1796, when English physician and scientist Edward Jenner established the efficacy of the very first vaccine after proving that people inoculated with cowpox became immune to smallpox, the link between veterinary medicine and human medicine has been the source of countless breakthroughs. It has inspired treatments for HIV (from the feline FIV), HPV (Human Papillomavirus based on research conducted on cattle), and recently, malaria. History has taught us that in order to overcome our greatest biological threats; we must adopt the 'One Health' approach to knowledge sharing among professionals in the fields of veterinary and human medicine.” Dr. Yair Saar, Founder & CEO
Indastrial Zone Mifaley Haemek, P.O.Box 73, Migdal HaEmek 2310000